Back to top
more

Addus HomeCare (ADUS)

(Real Time Quote from BATS)

$105.82 USD

105.82
4,106

+0.86 (0.82%)

Updated Aug 4, 2025 10:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Addus HomeCare Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Addus HomeCare has been struggling lately, but the selling pressure may be coming to an end soon.

Debanjana Dey headshot

3 Affordable MedTech Growth Stocks to Buy Amid Market Unrest

by Debanjana Dey

Here are some MedTech stocks which might be a solid investment option amid the coronavirus-battered market conditions.

Zacks Equity Research

Healthcare for Silver Years to Aid Encompass Health (EHC)

by Zacks Equity Research

Encompass Health's (EHC) inpatient rehabilitation and home hospice businesses are poised to grow on the back of aging population.

Zacks Equity Research

Encompass Health to Build Rehabilitation Hospital in Illinois

by Zacks Equity Research

Encompass Health (EHC) plans to build a rehabilitation facility in Illinois to serve the local community. The healthcare home will be launched in 2022 spring and complement other units in the area.

Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

by Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

3 Reasons Growth Investors Will Love Addus HomeCare (ADUS)

by Zacks Equity Research

Addus HomeCare (ADUS) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

ADUS or USPH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Addus HomeCare (ADUS) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

Addus HomeCare (ADUS) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for January 21st

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st.

Zacks Equity Research

What Makes Addus HomeCare (ADUS) a Strong Momentum Stock: Buy Now?

by Zacks Equity Research

Does Addus HomeCare (ADUS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

DGX or ADUS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

DGX vs. ADUS: Which Stock Is the Better Value Option?

Zacks Equity Research

3 Reasons Why Addus HomeCare (ADUS) Is a Great Growth Stock

by Zacks Equity Research

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Addus HomeCare (ADUS) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 6.90% and 5.37%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

The Zacks Analyst Blog Highlights: NRG, AquaVenture, Addus, Amedisys and Bluerock Residential

by Zacks Equity Research

The Zacks Analyst Blog Highlights: NRG, AquaVenture, Addus, Amedisys and Bluerock Residential

Nalak Das headshot

5 Top Stocks to Gain From Fed's Stable Monetary Stance

by Nalak Das

Fed was compelled to reduce it in three consecutive and equal tranches of 25 basis points to sustain the expansion of the U.S. economy.

Zacks Equity Research

Addus HomeCare (ADUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Looking for a Growth Stock? 3 Reasons Why Addus HomeCare (ADUS) is a Solid Choice

by Zacks Equity Research

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

What's in Store for Thermo Fisher (TMO) in Q3 Earnings?

by Zacks Equity Research

Developments in business segments are likely to have aided Thermo Fisher (TMO) in the third quarter.

Zacks Equity Research

Can Sequencing Products Drive Illumina's (ILMN) Q3 Earnings?

by Zacks Equity Research

Illumina (ILMN) is taking a cautious approach after a disappointing second quarter.

Zacks Equity Research

Why the Earnings Surprise Streak Could Continue for Addus HomeCare (ADUS)

by Zacks Equity Research

Addus HomeCare (ADUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

3 Reasons Why Addus HomeCare (ADUS) Is a Great Growth Stock

by Zacks Equity Research

Addus HomeCare (ADUS) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

DGX vs. ADUS: Which Stock Is the Better Value Option?

by Zacks Equity Research

DGX vs. ADUS: Which Stock Is the Better Value Option?

Zacks Equity Research

Addus HomeCare (ADUS) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 3.70% and 2.07%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for July 16th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 16th.